Workflow comparison

One project context or a chain of handoffs

A conventional research stack can be powerful because each specialist tool is mature. Its cost is the manual work required to move sources, context, decisions, files, and citations between them.

Kosmico's design bet is that research improves when specialist surfaces share one project state and the agent can act across them with explicit permissions.

Specialist tools remain valid choices

Zotero, Overleaf, notebooks, academic databases, and team chat each solve important problems. A team may prefer them for established workflows, institutional integrations, or a specific specialist capability.

The integration cost should be measured

Manual actions, application switches, duplicated context, stale copies, recovery after interruption, and artifact completeness are benchmark outcomes, not cosmetic details. The controlled benchmark holds the model and corpus constant to measure that workflow layer.

CriterionKosmicoConventional stack
ContextOne project context selected for the taskContext copied or reconnected across applications
ArtifactsLiterature, notes, code, references, and manuscript in one projectArtifacts remain in their specialist tools
AutomationAgent actions across supported project surfaces and permissionsIntegrations, exports, scripts, and manual handoffs
ControlOne workspace policy and project permissionsIndependent permissions, storage, and policies per service

Official live source

Current product facts

The live product profile is temporarily unavailable. This page is withholding changeable product facts until the official source responds.

Direct answers

Does Kosmico claim every specialist feature is stronger?

No. The claim being tested is workflow integration. Specialist tools may remain preferable for particular capabilities or established institutional processes.

How will the integration benefit be measured?

The benchmark measures completion, wall and human time, manual actions, application switches, artifact completeness, recovery, evidence quality, and cost across both real-world and controlled conditions.